Position in SYRE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$38,325,792
+$35,603,546 QoQ
Shares Held
431,694
+699.9% QoQ
Ownership
0.490%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#42
of 266 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 90%
None 10%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,483,663,924 across 196 Biotechnology names. SYRE ranks #12 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | TWST |
Twist Bioscience Corp
|
671,866 | $69,121,573 | |
| 4 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 |
All Filings in SYRE
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,325,792 | 431,694 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,722,246 | 53,970 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $893,594 | 27,277 | Shares | Defined | 2026-02-12 | |
| 2025-06-30 | $203,427 | 13,589 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $166,964 | 10,348 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $244,323 | 10,495 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $333,832 | 11,351 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $272,880 | 11,607 | Shares | Defined | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||